A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 31

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

221

HTML

2078

Figures (1-3)

138

Tables (1-2)

128

Sum=2565

Aug 21, 2007 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 21, 2007; 13(31): 4264-4267
Published online Aug 21, 2007. doi: 10.3748/wjg.v13.i31.4264

Figure 1 Virological response. Pecentages of patients with negative HBV DNA within 48 wk among the treated patients.

Figure 2 Virological response: mean HBV DNA levels according to PCR within 48 wk among the treated patients.

Figure 3 Biochemical response. Pecentages of patients with ALT normalization within 48 wk among the treated patients.

Citation: Ren FY, Piao DM, Piao XX. A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B. World J Gastroenterol 2007; 13(31): 4264-4267
URL: https://www.wjgnet.com/1007-9327/full/v13/i31/4264.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i31.4264